Top compounds associated with response to SPRY1


Feature Type Standardized
Nominal ANOVA
mRNA CP724714 GDSC1000 pan-cancer AAC 0.065 0.07
mRNA embelin GDSC1000 pan-cancer AAC 0.068 0.07
mRNA SN-38 GDSC1000 pan-cancer AAC -0.064 0.07
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.07
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC -0.1 0.07
mRNA Axitinib FIMM pan-cancer AAC 0.28 0.07
mRNA KU-0063794 CTRPv2 pan-cancer AAC 0.066 0.07
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.066 0.08
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.08
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.067 0.08
Download CSV